0.3775

0.67% +0.0025

After Hours: .3775

Tharimmune Inc (THAR)

Overview News Price History Financials Why THAR Down? Discussions Forecast

Tharimmune Inc stock is currently priced at $0.3775, with a 24-hour trading volume of 86,259. It has seen a +0.67% increased in the last 24 hours and a -18.87% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.371 pivot point. If it approaches the $0.379 resistance level, significant changes may occur.

Previous Close:

$0.375

Open:

$0.3887

24h Volume:

86,259

Market Cap:

$4.42M

Revenue:

Net Income/Loss:

$-9.32M

P/E Ratio:

-0.5243

EPS:

-0.72

Net Cash Flow:

$-7.30M

1W Performance:

+4.54%

1M Performance:

-18.87%

6M Performance:

+143.55%

1Y Performance:

+0.00%

1D Range:

$0.37

$0.3887

52W Range:

$0.1434

$4.79

Tharimmune Inc Stock (THAR) Company Profile

Name

Tharimmune Inc

Sector

Healthcare (1190)

Industry

Biotechnology (685)

Phone

908 955 3140

Address

1200 Route 22 East, Suite 2000, Bridgewater

Employee

Twitter

Next Earnings Date

Latest SEC Filings

THAR's Discussions on Twitter

Tharimmune Inc Stock (THAR) Latest News

Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying

Benzinga

Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Benzinga

Crude Oil Surges 2%; Tharimmune Shares Plummet

Benzinga

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Tharimmune (THAR) Up on Positive Data From Pipeline Candidate

Zacks Investment Research

US Stocks Mixed; House Prices Rise In September

Benzinga

Tharimmune Inc Stock (THAR) Financials Data

Tharimmune Inc (THAR) Net Income 2024

THAR net income (TTM) was -$9.32 million for the quarter ending December 31, 2023, a -9.98% decrease year-over-year.

Tharimmune Inc (THAR) Cash Flow 2024

THAR recorded a free cash flow (TTM) of -$7.30 million for the quarter ending December 31, 2023, a -11.32% decrease year-over-year.

Tharimmune Inc (THAR) Earnings per Share 2024

THAR earnings per share (TTM) was -$12.71 for the quarter ending December 31, 2023, a +32.10% growth year-over-year.

Tharimmune Inc Stock (THAR) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
MILBY RANDY	CEO	Nov 30 '23	Buy	1.00	10,000	10,000	127,517

Tharimmune, Inc., a biotechnology company, engages in developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. Its early-stage immuno-oncology pipeline includes antibodies targeting epitopes against validated targets in various solid tumors. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is based in Bridgewater, New Jersey.